基本信息
浏览量:306
职业迁徙
个人简介
Mark McClellan is Director and Robert J. Margolis, M.D., Professor of Business, Medicine and Policy at the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence and more effective drug and device innovation. His current work on responding to the COVID-19 public health emergency spans virus containment and testing strategies, reforming health care toward more resilient models of delivering care, and accelerating the development of therapeutics and vaccines. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. Dr. McClellan is an independent board member on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and serves as an advisor for Blackstone Life Sciences, Arsenal Capital Partners, and MITRE.
研究兴趣
论文共 111 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Circulationno. 18 (2023): 1417-1439
JAMA HEALTH FORUMno. 10 (2022): e224449-e224449
CLINICAL PHARMACOLOGY & THERAPEUTICSno. 1 (2022): 25-27
CLINICAL PHARMACOLOGY & THERAPEUTICSno. 1 (2022): 150-154
NEJM Catalystno. 7 (2021)
Mark McClellan, Rahul Rajkumar, Marion Couch, Diane Holder, Mai Pham,Peter Long, Rhonda Medows,Amol Navathe, Lewis Sandy,William Shrank,Mark Smith
NAM perspectives (2021)
Theresa Schmidt, Tom Valuck, Brittany Perkins, Jacqlyn Riposo, Palak Patel,Kimberly Westrich,Ethan Basch,Mark McClellan
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn